These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 722725)

  • 1. Aromatic hydroxylation of beta-adrenergic antagonists. 4- and 5-hydroxylation of 1-(isopropylamino)-3-[2-(allyloxy)phenoxy]-2-propanol (oxprenolol).
    Nelson WL; Burke TR
    J Med Chem; 1978 Dec; 21(12):1185-6. PubMed ID: 722725
    [No Abstract]   [Full Text] [Related]  

  • 2. Aromatic hydroxylation of beta-adrenergic antagonists. Formation of 4'- and 5'-hydroxy-1-(isopropylamino)-3-[2'-allyloxy)phenoxy]-2-propanol from oxprenolol.
    Nelson WL; Burke TR
    J Med Chem; 1979 Sep; 22(9):1082-8. PubMed ID: 490553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of beta-adrenergic antagonists. Evidence for an arene oxide-NIH shift pathway in the aromatic hydroxylation of oxprenolol.
    Nelson WL; Burke TR
    J Med Chem; 1979 Sep; 22(9):1088-92. PubMed ID: 490554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatic hydroxylation of oxprenolol. Quantitation and stereoselectivity in the formation of 4'- and 5-hydroxyoxprenolol in vivo in the rat.
    Burke TR; Howald WN; Nelson WL
    Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):399-412. PubMed ID: 7403656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-methylation, a newly identified pathway in the dog for the metabolism of oxprenolol, a beta-receptor blocking agent.
    Leeson GA; Garteiz DA; Knapp WC; Wright GJ
    Drug Metab Dispos; 1973; 1(3):565-8. PubMed ID: 4149450
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of 4'- and 5'-hydroxyoxprenolol:pharmacologically active ring-hydroxylated metabolites of oxprenolol.
    Burke TR; Nelson WL; Buckner CK
    J Med Chem; 1979 Dec; 22(12):1535-7. PubMed ID: 536997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron impact fragmentation studies of beta-blocking drugs and their metabolites by GC-mass spectroscopy.
    Garteiz DA; Walle T
    J Pharm Sci; 1972 Nov; 61(11):1728-31. PubMed ID: 4147389
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of heparine-induced increment of rat free fatty acids by oxprenolol.
    Bartsokas SK; Trichopoulou-Polychronopoulou AD; Charissiadou A; Valsamakis S; Kalaitjidou C
    Arzneimittelforschung; 1975 May; 25(5):774-5. PubMed ID: 1242320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physico-chemical properties and hydrolysis of oxprenolol octanoyl and benzoyl esters.
    Nogowska M
    Acta Pol Pharm; 2000; 57(1):43-7. PubMed ID: 10846796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolites of oxprenolol (Trasicor) in man.
    Riess W; Huerzeler H; Raschdorf F
    Xenobiotica; 1974 Jun; 4(6):365-73. PubMed ID: 4842016
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical aspects of metoprolol metabolism. Asymmetric synthesis and absolute configuration of the 3-[4-(1-hydroxy-2-methoxyethyl)phenoxy]-1-(isopropylamino)-2-propanols , the diastereomeric benzylic hydroxylation metabolites.
    Shetty HU; Nelson WL
    J Med Chem; 1988 Jan; 31(1):55-9. PubMed ID: 3336032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-dealkylation of oxprenolol: formation of 3-aryloxypropane-1,2-diol, 3-aryloxylactic acid, and 2-aryloxyacetic acid metabolites in the rat.
    Nelson WL; Bartels MJ
    J Pharm Sci; 1985 Jan; 74(1):33-6. PubMed ID: 3981414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the structure of partially methylated sugars as O-trimethylsilyl ethers by gas chromatography-mass spectrometry.
    Matsubara T; Hayashi A
    Biomed Mass Spectrom; 1974 Feb; 1(1):62-5. PubMed ID: 4433718
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemical trapping of labile aldehyde intermediates in the metabolism of propranolol and oxprenolol.
    Goldszer F; Tindell GL; Walle UK; Walle T
    Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):193-205. PubMed ID: 7335950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxprenolol hydrochloride: pharmacology, pharmacokinetics, adverse effects and clinical efficacy.
    Russo ME; Covinsky JO
    Pharmacotherapy; 1983; 3(2 Pt 1):68-81. PubMed ID: 6344036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the relationship between the structure and physicochemical parameters of a homologous series of oxprenolol esters at various pH values and temperatures.
    Jordan CG
    J Pharm Sci; 1997 Oct; 86(10):1085-91. PubMed ID: 9344162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. -Hydroxy fatty acids in sphingolipids of Tetrahymena.
    Ferguson KA; Conner RL; Mallory FB; Mallory CW
    Biochim Biophys Acta; 1972 May; 270(1):111-6. PubMed ID: 4624829
    [No Abstract]   [Full Text] [Related]  

  • 18. Amobarbital metabolism in man. Determination of N-hydroxyamobarbital and 3'-hydroxyamobarbital in urine by gas chromatography chemical ionization mass spectrometry.
    Tang BK; Inaba T; Kalow W
    Biomed Mass Spectrom; 1977 Apr; 4(2):73-6. PubMed ID: 884208
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of isoproterenol activation of adenylate cyclase by metoprolol, oxprenolol, and the para isomer of oxprenolol.
    Petrack B; Czernik AJ
    Mol Pharmacol; 1976 Mar; 12(2):203-7. PubMed ID: 4723
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of urinary and biliary metabolites of alprenolol in the rat.
    Hoffmann KJ; Arfwidsson A; Borg KO; Skånberg I
    Xenobiotica; 1979 Feb; 9(2):93-106. PubMed ID: 433314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.